Tamás Pintér

13.6k citations
52 papers · 5.9k · 2 hit papers · h-index 18

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Cancer Treatment and Pharmacology 12
    • HER2/EGFR in Cancer Research 6
    • Colorectal Cancer Treatments and Studies 6
    • Advanced Breast Cancer Therapies 15
    • Brain Metastases and Treatment 3
    • Lung Cancer Treatments and Mutations 3

Tamás Pintér

47 papers receiving 5.8k citations

Tamás Pintér's Hit Papers

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study 2014 · 1.4k citations
1.4k0+5+11Years since publication50010001.5k2.0k2.5k

Peers

Tamás Pintér
Comparison fields: 5 of 98
  • Oncology 3.6k
  • Hepatology 553
  • Pulmonary and Respiratory Medicine 2.2k
  • Cancer Research 963
  • Genetics 361
Replace Rafael G. Amado with:
Rafael G. Amado United States
Samuel E. DePrimo United States
Napoleone Ferrara United States
Silvio Veronese Italy
Mikhail Lichinitser Russia
Takayuki Kosaka Japan
Rogério Lilenbaum United States
Beth Overmoyer United States
Gwen Fyfe United States
Milo Frattini Italy
Tamás Pintér relative to Rafael G. Amado United States Rafael G. Amado's profile →
Citations per field
00.5×1.5×2.2×
Rafael G. Amado · 1×
Citations per year

Countries citing papers authored by Tamás Pintér

Since Specialization
Citations

This map shows the geographic impact of Tamás Pintér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Pintér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Pintér more than expected).

Fields of papers citing papers by Tamás Pintér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Pintér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Pintér. The network helps show where Tamás Pintér may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamás Pintér, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamás Pintér Line = papers co-authored together Tamás Pintér links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Hit paper breakdown →
20092914
2
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Hit paper breakdown →
20141435
3 2003291
4 2008156
5 2008153
6 2016138
7 2004121
8 2020119
9 2012113
10 2012102
11 201753
12 201340
13
Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel
200440
14 201437
15 200925
16 201623
17 200922
18 201319
19 201016
20 20129

About Tamás Pintér

Tamás Pintér is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Hematology, having authored 52 papers that have together received 5.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (15 papers), Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Erythropoietin and Anemia Treatment (4 papers), Brain Metastases and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (3.6k citations), Hepatology (553 citations), Pulmonary and Respiratory Medicine (2.2k citations), Cancer Research (963 citations) and Genetics (361 citations). Tamás Pintér has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include J. Załuski, Eric Van Cutsem, Robert Lim, Christopher Stroh, G. Bodoky, Johannes Nippgen, Geert D’Haens, Anatoly Makhson, Jae Kyung Roh and Gunnar Folprecht. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Acta Oncologica and Clinical Breast Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact